These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5216594)

  • 1. Pseudohyperkalemia due to release of potassium from white blood cells during clotting.
    Bronson WR; DeVita VT; Carbone PP; Cotlove E
    N Engl J Med; 1966 Feb; 274(7):369-75. PubMed ID: 5216594
    [No Abstract]   [Full Text] [Related]  

  • 2. [Liberation of platelet potassium during coagulation].
    Cocconi G; Carrara G
    Hemostase; 1965 Sep; 5(3):253-63. PubMed ID: 5216449
    [No Abstract]   [Full Text] [Related]  

  • 3. Pseudohyperkalemia secondary to postsplenectomy thrombocytosis.
    Johnson CM; Hughes KM
    Am Surg; 2001 Feb; 67(2):168-70. PubMed ID: 11243543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudohyperkalemia and extreme leukocytosis.
    Bellevue R; Dosik H; Spergel G; Gussoff BD
    J Lab Clin Med; 1975 Apr; 85(4):660-4. PubMed ID: 1120932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pseudohyperkalemia in serum: the phenomenon and its clinical magnitude.
    Sevastos N; Theodossiades G; Efstathiou S; Papatheodoridis GV; Manesis E; Archimandritis AJ
    J Lab Clin Med; 2006 Mar; 147(3):139-44. PubMed ID: 16503244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of magnitude of pseudohyperkalemia in thrombocytosis.
    Kim HJ; Chung CH; Moon CO; Park CG; Hong SP; Oh MS; Carroll HJ
    Korean J Intern Med; 1990 Jul; 5(2):97-100. PubMed ID: 2098099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pseudohyperkalemia - Potassium released from cells due to clotting and centrifugation - a case report.
    Šálek T
    Biochem Med (Zagreb); 2018 Feb; 28(1):011002. PubMed ID: 29472808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pitfall in intraoperative electrolyte management for a patient with pseudohyperkalemia caused by thrombocytosis].
    Nomura M; Nakasuji M; Nakamura M; Imanaka N; Tanaka M; Kawashima H
    Masui; 2009 Oct; 58(10):1300-2. PubMed ID: 19860239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing evidence-based thresholds and laboratory practices to reduce inappropriate treatment of pseudohyperkalemia.
    Ranjitkar P; Greene DN; Baird GS; Hoofnagle AN; Mathias PC
    Clin Biochem; 2017 Aug; 50(12):663-669. PubMed ID: 28288853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence, risk factors, and recognition of pseudohyperkalemia in patients with chronic lymphocytic leukemia.
    Bnaya A; Ruchlemer R; Itzkowitz E; Gabbay E; Mosenkis A; Shavit L
    Int J Hematol; 2021 Jul; 114(1):102-108. PubMed ID: 33782816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postsplenectomy thrombocytosis and pseudohyperkalemia in trauma: a case report and review of literature.
    Ahmed R; Isaac AM
    J Trauma; 2009 Jul; 67(1):E17-9. PubMed ID: 18277301
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pseudohyperkalemia in the serum in reactive thrombocytosis and thrombocythemia].
    Mödder B; Meuthen I
    Dtsch Med Wochenschr; 1986 Feb; 111(9):329-32. PubMed ID: 3948731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pseudohyperkalemia: clinical chemistry for the clinician].
    Gritter M; Ramakers C; de Man RA; Hoorn EJ; Rotmans JI
    Ned Tijdschr Geneeskd; 2022 Jun; 166():. PubMed ID: 35736384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudohyperkalaemia is a common finding in myeloproliferative disorders that may lead to inappropriate management of patients.
    Ong YL; Deore R; El-Agnaf M
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e151-7. PubMed ID: 19016918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spontaneous cyclic leukocytosis and thrombocytosis in chronic granulocytic leukemia.
    Vodopick H; Rupp EM; Edwards CL; Goswitz FA; Beauchamp JJ
    N Engl J Med; 1972 Feb; 286(6):284-90. PubMed ID: 4500260
    [No Abstract]   [Full Text] [Related]  

  • 16. Pseudohyperkalemia in chronic lymphocytic leukemia: Prevalence, impact, and management challenges.
    Bnaya A; Ganzel C; Shavit L
    Am J Med Sci; 2023 Sep; 366(3):167-175. PubMed ID: 37285937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pseudohyperkalemia: Three Cases and a Review of Literature.
    Saleh-Anaraki K; Jain A; Wilcox CS; Pourafshar N
    Am J Med; 2022 Jul; 135(7):e150-e154. PubMed ID: 35398330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudohyperkalemia in Chronic Lymphocytic Leukemia. Longitudinal Analysis and Review of the Literature.
    Katkish L; Rector T; Ishani A; Gupta P
    Minn Med; 2015 Jul; 98(7):45-6. PubMed ID: 26267922
    [No Abstract]   [Full Text] [Related]  

  • 19. [Draft proposal to estimate true values of serum potassium in samples from patients with myeloproliferative neoplasma].
    Hishiki K; Toyama M; Sato R; Suzuki I; Kisugi R; Koike M; Nishiwaki K; Masuoka H; Yoshida H
    Rinsho Byori; 2012 Jun; 60(6):516-22. PubMed ID: 22880228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudohyperkalemia in a patient with chronic lymphoblastic leukemia and tumor lysis syndrome.
    Kintzel PE; Scott WL
    J Oncol Pharm Pract; 2012 Dec; 18(4):432-5. PubMed ID: 22190579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.